GSK and University of Nottingham collaborate to create Centre of Excellence for sustainable chemistry
26 April 2012 | By GlaxoSmithKline
Innovative carbon neutral laboratory to be established on University Campus...
List view / Grid view
News
5th Tecan Symposium to visit Boston in the fall
26 April 2012 | By Tecan
The annual Tecan Symposium will be held in the US for the first time this year...
David Brennan to retire as AstraZeneca’s Chief Executive Officer
26 April 2012 | By AstraZeneca
AstraZeneca announced that Chief Executive Officer and Board member, David Brennan has decided to retire...
Amgen receives Complete Response Letter from FDA for XGEVA® sBLA for prevention of bone metastases
26 April 2012 | By Amgen
The FDA cannot approve the application in its present form...
DiversityInc names Lilly a top company for diversity
25 April 2012 | By Eli Lilly and Company
Eli Lilly and Company has been named to the 2012 DiversityInc Top 50 Companies for Diversity list...
AstraZeneca and The Medicines Company announce global collaboration in acute ischaemic heart disease
25 April 2012 | By AstraZeneca
AstraZeneca and The Medicines Company announced a global collaboration...
Novartis drug Signifor® approved in the EU as the first medication to treat patients with Cushing’s disease
25 April 2012 | By Novartis
Novartis announced that the European Commission has approved Signifor®...
Amgen to acquire Mustafa Nevzat
25 April 2012 | By Amgen
Amgen and Mustafa Nevzat Pharmaceuticals have announced an agreement under which Amgen will acquire 95.6 percent of shares in MN...
B&W Tek is awarded patent for mounting fiber spectroscopic probes on to microscope
24 April 2012 | By B&W Tek Inc
B&W Tek, Inc., has announced its 18th patent since the company’s establishment in 1997...
Gerresheimer presents innovative solutions at Interphex N.Y.
24 April 2012 | By Gerresheimer AG
Gerresheimer will be displaying its comprehensive range of tubular glass based primary packaging solutions at Interphex...
Novo Nordisk and Oxford University team up to develop novel treatments for rheumatoid arthritis
24 April 2012 | By Novo Nordisk
Novo Nordisk and the Oxford University announce a new partnership...
AstraZeneca to acquire Ardea Biosciences for $1 billion (net of existing cash)
23 April 2012 | By AstraZeneca
Deal includes lead product lesinurad in Phase III development for gout...
Takeda and AMAG receive a positive CHMP opinion in Europe for Rienso® (ferumoxytol)
23 April 2012 | By Takeda Pharmaceutical Company Limited
For the treatment of iron deficiency anaemia in adult chronic kidney disease patients...
FORXIGA (dapagliflozin) receives positive CHMP opinion in the EU for the treatment of type 2 diabetes
23 April 2012 | By AstraZeneca
In combination with other glucose-lowering medicinal products including insulin...
GlaxoSmithKline reaches agreement to divest non-core OTC brands for £164 million
23 April 2012 | By GlaxoSmithKline Plc
Announcement follows divestment of brands in USA, Canada & Europe...
